Canary Capital Launches the First U.S. Spot Staked INJ ETF (Ticker: INJC)
Key Highlights
- ➤Canary Capital launches Nasdaq-listed Canary Staked INJ ETF (INJC)
- ➤INJC seeks INJ price exposure plus net staking rewards
- ➤Injective tokenized over 1 Billion in assets to date
- ➤Injective processed more than 3.13 billion transactions as of October 22nd, 2026
- ➤Injective burned more than 7.27 million INJ through monthly buybacks
Expert Statements
Steven McClurg, CEO of Canary Capital
“The Canary Staked INJ ETF gives investors access to a blockchain purpose-built for finance through a familiar exchange-traded structure, while also enabling investors to benefit from potential staking rewards”
Steven McClurg, CEO of Canary Capital
“Injective was designed from the ground up for trading, tokenization, markets, and financial applications. We believe investors are increasingly looking past the largest digital assets and toward the specialized networks building the next generation of on-chain financial infrastructure.”
Eric Chen, Co-Founder of Injective Foundation
“Investors can now gain exposure to INJ through the brokerage accounts they already use”
Eric Chen, Co-Founder of Injective Foundation
“We built Injective to bring financial markets onchain. Canary’s launch connects that mission to a broader base of investors, giving them a familiar way to access the asset that powers Injective.”
BRENTWOOD, Tenn., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Canary Capital Group LLC ("Canary Capital"), a digital asset investment management firm, today announced the launch of the Canary Staked INJ ETF (Ticker: INJC), listed on Nasdaq. The Fund seeks to provide exposure to the price of INJ, the native token of the Injective blockchain network. In addition, the Fund also seeks to earn additional INJ through participation in the Injective network's proof-of-stake validation process, with net staking rewards reflected in the Fund's net asset value.
"The Canary Staked INJ ETF gives investors access to a blockchain purpose-built for finance through a familiar exchange-traded structure, while also enabling investors to benefit from potential staking rewards," said Steven McClurg, CEO of Canary Capital. "Injective was designed from the ground up for trading, tokenization, markets, and financial applications. We believe investors are increasingly looking past the largest digital assets and toward the specialized networks building the next generation of on-chain financial infrastructure."
Get started
Create a free account to read the full story.